BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37601096)

  • 1. The significance of ERK5 catalytic-independent functions in disease pathways.
    Le NT
    Front Cell Dev Biol; 2023; 11():1235217. PubMed ID: 37601096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases.
    Kassouf T; Sumara G
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32872540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The signaling pathway leading to extracellular signal-regulated kinase 5 (ERK5) activation via G-proteins and ERK5-dependent neurotrophic effects.
    Obara Y; Nakahata N
    Mol Pharmacol; 2010 Jan; 77(1):10-6. PubMed ID: 19858097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.
    Cargnello M; Roux PP
    Microbiol Mol Biol Rev; 2011 Mar; 75(1):50-83. PubMed ID: 21372320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5.
    Déléris P; Rousseau J; Coulombe P; Rodier G; Tanguay PL; Meloche S
    J Cell Physiol; 2008 Dec; 217(3):778-88. PubMed ID: 18720373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif.
    Aberg E; Torgersen KM; Johansen B; Keyse SM; Perander M; Seternes OM
    J Biol Chem; 2009 Jul; 284(29):19392-401. PubMed ID: 19473979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity assays for extracellular signal-regulated kinase 5.
    Nakamura K; Johnson GL
    Methods Mol Biol; 2010; 661():91-106. PubMed ID: 20811978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
    Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL
    J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5.
    Kant S; Schumacher S; Singh MK; Kispert A; Kotlyarov A; Gaestel M
    J Biol Chem; 2006 Nov; 281(46):35511-9. PubMed ID: 16973613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway.
    Déléris P; Trost M; Topisirovic I; Tanguay PL; Borden KL; Thibault P; Meloche S
    J Biol Chem; 2011 Feb; 286(8):6470-8. PubMed ID: 21177870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif.
    Barsyte-Lovejoy D; Galanis A; Clancy A; Sharrocks AD
    Biochem J; 2004 Aug; 381(Pt 3):693-9. PubMed ID: 15132737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos.
    Gilley R; March HN; Cook SJ
    Cell Signal; 2009 Jun; 21(6):969-77. PubMed ID: 19249353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical mitogen-activated protein kinases: structure, regulation and functions.
    Coulombe P; Meloche S
    Biochim Biophys Acta; 2007 Aug; 1773(8):1376-87. PubMed ID: 17161475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2.
    Perander M; Al-Mahdi R; Jensen TC; Nunn JA; Kildalsen H; Johansen B; Gabrielsen M; Keyse SM; Seternes OM
    Sci Rep; 2017 Mar; 7():43471. PubMed ID: 28252035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5.
    Marinissen MJ; Chiariello M; Pallante M; Gutkind JS
    Mol Cell Biol; 1999 Jun; 19(6):4289-301. PubMed ID: 10330170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPK signalling: ERK5 versus ERK1/2.
    Nishimoto S; Nishida E
    EMBO Rep; 2006 Aug; 7(8):782-6. PubMed ID: 16880823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation and properties of MAPKs.
    Raman M; Chen W; Cobb MH
    Oncogene; 2007 May; 26(22):3100-12. PubMed ID: 17496909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin.
    Charlson AT; Zeliadt NA; Wattenberg EV
    Toxicol Appl Pharmacol; 2009 Dec; 241(2):143-53. PubMed ID: 19716839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts.
    Kesavan K; Lobel-Rice K; Sun W; Lapadat R; Webb S; Johnson GL; Garrington TP
    J Cell Physiol; 2004 Apr; 199(1):140-8. PubMed ID: 14978743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.